RxSight, Inc. (RXST) [Rocket]

In millions, except per share items	Dec-31-22	Dec-05-22	Dec-31-21	Dec-05-21	Dec-31-20	Dec-31-19
	10-K	8-K	10-K	8-K	10-K	S-1/A
Revenues	49.0	49.0	22.6	22.6	14.7	2.2
Revenue growth	116.9%	116.9%	53.9%		555.0%
Cost of goods sold	27.7	27.7	18.1	18.1	13.0	4.1
Gross profit	21.3	21.3	4.5	4.5	1.7	-1.8
Gross margin	43.5%	43.5%	20.0%	20.0%	11.6%	-81.2%
Selling, general and administrative	58.7	58.7	32.8	32.8	37.1	15.2
Research and development	26.0	26.0	24.5	24.5		29.6
Other operating expenses					0.0	-0.5
EBITDA [+]	-59.4		-48.8		-31.5	-42.3
EBITDA growth	21.8%	19.9%	54.8%		-25.5%
EBITDA margin	-121.3%	-129.2%	-216.0%	-233.6%	-214.8%	-1888.1%
Depreciation and amortization	3.9		4.0		3.9	3.8
EBIT [+]	-63.3	-63.3	-52.8	-52.8	-35.4	-46.1
EBIT growth	19.9%	19.9%	49.2%		-23.2%
EBIT margin	-129.2%	-129.2%	-233.6%	-233.6%	-241.0%	-2055.8%
Interest expense, net [+]	4.9	4.9	3.7	3.7		-2.3
Interest expense	4.9	4.9	3.7	3.7	0.5
Interest income						2.3
Other income (expense), net [+]	1.5	1.5	7.8	7.8	63.5	170.0
Gain (loss) on foreign currency transactions						0.0
Change in fair value of warrants			-2.7		-63.0
Pre-tax income	-66.7	-66.7	-48.7	-48.7	27.6	126.2
Income taxes	0.0	0.0	0.0	0.0	0.1	0.0
Tax rate					0.2%	0.0%
Net income	-66.8	-66.8	-48.7	-48.7	27.6	126.2
Net margin	-136.2%	-136.2%	-215.5%	-215.5%	187.9%	5632.3%

Basic EPS [+]	($2.41)		($3.57)		$7.44	$26,127.00
Growth	-32.5%		-148.0%		-100.0%
Diluted EPS [+]	($2.41)		($3.57)		$4.98	$26,127.00
Growth	-32.5%		-171.7%		-100.0%

Shares outstanding (basic) [+]	27.7		13.6		3.7	0.0
Growth	103.0%		267.5%		76637.6%
Shares outstanding (diluted) [+]	27.7		13.6		5.5	0.0
Growth	103.0%		146.3%		114416.3%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.